Pacer Advisors Inc. boosted its holdings in Varian Medical Systems, Inc. (NYSE:VAR) by 24.1% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 10,158 shares of the medical equipment provider’s stock after buying an additional 1,970 shares during the period. Pacer Advisors Inc.’s holdings in Varian Medical Systems were worth $1,383,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of VAR. Arrow Financial Corp purchased a new stake in Varian Medical Systems in the 2nd quarter worth $27,000. Permanens Capital L.P. bought a new stake in Varian Medical Systems in the first quarter valued at $28,000. Quantamental Technologies LLC bought a new stake in shares of Varian Medical Systems during the second quarter worth $29,000. Financial Gravity Wealth Inc. grew its holdings in shares of Varian Medical Systems by 1,646.2% during the second quarter. Financial Gravity Wealth Inc. now owns 227 shares of the medical equipment provider’s stock worth $31,000 after purchasing an additional 214 shares during the last quarter. Finally, Flagship Harbor Advisors LLC bought a new stake in shares of Varian Medical Systems during the second quarter worth $32,000. Hedge funds and other institutional investors own 91.31% of the company’s stock.

Several equities analysts have recently issued reports on the company. Robert W. Baird set a $158.00 price target on Varian Medical Systems and gave the company a “buy” rating in a research note on Friday, July 26th. Barrington Research reiterated a “buy” rating and set a $142.00 price target on shares of Varian Medical Systems in a report on Thursday, July 25th. Zacks Investment Research downgraded shares of Varian Medical Systems from a “strong-buy” rating to a “hold” rating and set a $139.00 price target on the stock. in a report on Saturday, July 27th. TheStreet downgraded shares of Varian Medical Systems from a “b” rating to a “c+” rating in a research note on Monday, August 5th. Finally, BTIG Research reiterated a “hold” rating on shares of Varian Medical Systems in a research note on Wednesday, July 24th. One research analyst has rated the stock with a sell rating, four have given a hold rating and six have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $141.22.

In other Varian Medical Systems news, insider Kolleen T. Kennedy sold 1,242 shares of the firm’s stock in a transaction on Wednesday, July 10th. The shares were sold at an average price of $137.99, for a total value of $171,383.58. Following the completion of the transaction, the insider now owns 27,633 shares of the company’s stock, valued at $3,813,077.67. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Timothy E. Guertin sold 12,651 shares of the stock in a transaction dated Monday, July 15th. The shares were sold at an average price of $135.21, for a total transaction of $1,710,541.71. Following the completion of the sale, the director now directly owns 13,589 shares in the company, valued at $1,837,368.69. The disclosure for this sale can be found here. Insiders sold a total of 72,063 shares of company stock worth $9,586,118 over the last three months. 0.78% of the stock is owned by company insiders.

Shares of NYSE:VAR traded down $1.70 during mid-day trading on Friday, reaching $117.85. 30,163 shares of the stock were exchanged, compared to its average volume of 682,132. The company has a market cap of $10.13 billion, a P/E ratio of 26.45, a P/E/G ratio of 3.01 and a beta of 0.87. Varian Medical Systems, Inc. has a one year low of $101.42 and a one year high of $142.50. The stock’s 50 day simple moving average is $111.52 and its 200-day simple moving average is $128.85.

Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings results on Wednesday, July 24th. The medical equipment provider reported $1.32 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.14 by $0.18. Varian Medical Systems had a return on equity of 24.91% and a net margin of 10.75%. The firm had revenue of $825.80 million during the quarter, compared to the consensus estimate of $762.29 million. During the same period last year, the company earned $1.04 earnings per share. The business’s revenue was up 16.5% compared to the same quarter last year. As a group, research analysts forecast that Varian Medical Systems, Inc. will post 4.62 EPS for the current fiscal year.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment.

See Also: Diversification in Your Portfolio

Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems, Inc. (NYSE:VAR).

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.